Two Sigma Advisers’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-333,000
Closed -$9.03M 2221
2015
Q4
$9.03M Buy
333,000
+125,600
+61% +$3.24M 0.05% 336
2015
Q3
$4.54M Sell
207,400
-90,800
-30% -$2.32M 0.03% 496
2015
Q2
$8.5M Sell
298,200
-82,500
-22% -$2.4M 0.06% 334
2015
Q1
$10.4M Buy
380,700
+62,600
+20% +$1.72M 0.08% 302
2014
Q4
$8.4M Buy
+318,100
New +$9.31M 0.06% 338

Other funds holding MR

Two Sigma Advisers's MR Position: Q1 2016 in Review

Two Sigma Advisers sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 333,000 shares — an estimated $9.03M sold.

Two Sigma Advisers first reported a position in MR in Q4 2014 and held it in 5 quarters. The position peaked at $10.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Two Sigma Advisers reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Two Sigma Advisers sold 333,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $9.03M.
  • Two Sigma Advisers first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 5 quarters.
  • Two Sigma Advisers's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $10.4M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Two Sigma Advisers's 13F filing for Q1 2016, filed 16 May 2016.